Thursday, 31 August 2017 11:07

Worldwide Recall Of Clindamycin Injection By Alvogen

Rate this item
(0 votes)

The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that Alvogen is conducting a voluntary recall of seven (7) lots of Clindamycin Injection USP ADD-Vantage Vials, manufactured for Alvogen by Hospira Inc., to the hospital/retail level.

Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible bacteria. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate.

Reason for recall

The recall was due to microbial growth detected during a routine simulation of the manufacturing process. This growth shows the potential for possible introduction of microorganisms into the product.

Possible associated risk

Administration of this product may cause adverse events, ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.

Details of affected products

Lot number Expiration Date Strength          NDC #
68-104-EV 07/31/2018 600mg/4mL 47781-463-69
68-105-EV 07/31/2018 900mg/6mL 47781-464-69
68-106-EV 07/31/2018 900mg/6mL 47781-464-69
73-154-EV 12/31/2018 300mg/2mL 47781-462-69
73-155-EV 12/31/2018 600mg/4mL 47781-463-69
73-156-EV 12/31/2018 600mg/4mL 47781-463-69
73-157-EV 12/31/2018 900mg/6mL 47781-464-69

Healthcare providers’ action

  • Healthcare providers in possession of the affected lots of product should discontinue their use and submit them to the nearest NAFDAC office.
  • Healthcare providers and patients should report adverse reactions associated with the use of this product to the nearest NAFDAC office, NAFDAC PRASCOR 920543 TOLL FREE from all networks) or via This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC…………..Safeguarding the health of the Nation!!!

Read 674 times Last modified on Thursday, 31 August 2017 11:10

ONLINE PORTALS

napams

Contact Us from Mon - Friday: 08:00-16:00 GMT+1

Write Us:

NAFDAC Corporate Headquarters,

Plot 2032, Olusegun, Obasanjo Way,

Zone 7, Wuse, Abuja, Nigeria

 

Lagos Operation Office:

Plot 1, Industrial Estate, Lagos- Oshodi Apapa Express Way, Isolo, Lagos, Nigeria

 

 

 

 

 

 

For Enquiries:

Call: +234(0)-1-4609750

Email:nafdac@nafdac.gov.ng

 

 

 

 

 

 

 

 

 

 

For Complaints:

Call: +234(0)907630506

Email:reforms@nafdac.gov.ng

Or Send Us a Complaint

 

 

 

 

 

 

 

 

 

Contact Other NAFDAC Offices Nationwide